Understanding sensitivity and cross‐reactivity of xylazine lateral flow immunoassay test strips for drug checking applications
Drug Testing and Analysis · 2024-09 · 16 (9) · 942-947
DOI: 10.1002/dta.3612 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Testing and Analysis, online erschienen am 03.12.2023. Verfasst von Edward Sisco und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Standards and Technology, Gaithersburg, Maryland, USA. Hauptthemen laut MEDLINE: Xylazine, Reagent Strips, Illicit Drugs, Cross Reactions. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
The continued prevalence of xylazine in the illicit drug market has necessitated development of quick and simple methods for identification, including lateral flow immunoassays (also known as “test strips”), like those frequently used to detect fentanyl. This study explored the drug checking applicability of the first publicly available xylazine test strips (XTS) using four sub‐studies: reproducibility (i.e., consistency of positive results in a highly‐concentrated xylazine solution); limit of detection on a calibration curve of xylazine concentrations; cross‐reactivity against 77 commonly encountered drugs, cutting agents, and other structurally similar compounds; and applicability for analyzing community‐acquired samples—where 100 drug residue samples were analyzed using XTS, direct analysis in real time mass spectrometry (DART‐MS), and gas chromatography tandem mass spectrometry (GC–MS/MS). XTS consistently detected xylazine at concentrations ≥2.5 μg/ml, and XTS results were reproducible. Sensitivity and specificity of XTS were calculated by comparing expected versus obtained results based on xylazine concentration of community‐acquired samples measured by GC‐MS/MS. XTS consistently detected xylazine in samples with concentration >2 μg/ml and yielded a sensitivity of 0.974, specificity of 1.00, and overall accuracy of 0.986. Cross‐reactivity with lidocaine, a common cutting agent, and lack of XTS reactivity with other α 2 ‐agonists found in the illicit drug supply highlight the need to offer consumers comprehensive drug checking services that identify a range of substances and better inform them about drug contents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute of Standards and Technology, Gaithersburg, Maryland, USA.
- Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
- Department of Forensic Sciences, George Washington University, Washington, DC, USA.
- Department of Epidemiology, New York University School of Global Public Health, New York, New York, USA.
ORCID-Profile: Edward Sisco
Zitieren
APA
Sisco, E., Nestadt, D. F., Bloom, M. B., Schneider, K. E., Elkasabany, R. A., Rouhani, S., & Sherman, S. G. (2024). Understanding sensitivity and cross‐reactivity of xylazine lateral flow immunoassay test strips for drug checking applications. Drug Testing and Analysis, 16(9), 942-947. https://doi.org/10.1002/dta.3612
Vancouver
Sisco E, Nestadt DF, Bloom MB, Schneider KE, Elkasabany RA, Rouhani S, et al. Understanding sensitivity and cross‐reactivity of xylazine lateral flow immunoassay test strips for drug checking applications. Drug Testing and Analysis. 2024;16(9):942-947. doi:10.1002/dta.3612
BibTeX
@article{Sisco2024,
author = {Sisco, Edward and Nestadt, Danielle F and Bloom, Madeline B and Schneider, Kristin E and Elkasabany, Rae A and Rouhani, Saba and Sherman, Susan G},
title = {Understanding sensitivity and cross‐reactivity of xylazine lateral flow immunoassay test strips for drug checking applications},
journal = {Drug Testing and Analysis},
year = {2024},
volume = {16},
number = {9},
pages = {942--947},
doi = {10.1002/dta.3612}
}
EUVIMED